MEP28908A - Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same - Google Patents

Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same

Info

Publication number: MEP28908A
Authority: ME; Montenegro
Prior art keywords: medicament; pentafluorosulfanyl; benzoylguanidine; utilization; production
Prior art date: 2002-05-18

Application number

MEP-289/08A

Other languages

Bosnian (bs)

English (en)

Inventor

Heinz-Werner Kleemann

Original Assignee

Sanofi Aventis Deutschland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-18

Filing date

2003-05-05

Publication date

2010-10-10

2003-05-05 Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland

2010-10-10 Publication of MEP28908A publication Critical patent/MEP28908A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Tropical Medicine & Parasitology (AREA)
Immunology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Oncology (AREA)
Transplantation (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Psychology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

MEP-289/08A 2002-05-18 2003-05-05 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same MEP28908A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10222192A DE10222192A1 (de)	2002-05-18	2002-05-18	Pentafluorsulfuranyl-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
PCT/EP2003/004669 WO2003097591A1 (de)	2002-05-18	2003-05-05	Pentafluorsulfanyl-benzoylguanidine, verfahren zu ihrer hertellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament

Publications (1)

Publication Number	Publication Date
MEP28908A true MEP28908A (en)	2010-10-10

Family

ID=29285565

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-289/08A MEP28908A (en)	2002-05-18	2003-05-05	Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same

Country Status (28)

Country	Link
EP (1)	EP1509498B1 (xx)
JP (1)	JP4383341B2 (xx)
KR (1)	KR100977676B1 (xx)
CN (1)	CN100506791C (xx)
AR (1)	AR040034A1 (xx)
AT (1)	ATE343563T1 (xx)
AU (1)	AU2003242531B2 (xx)
BR (1)	BR0311128A (xx)
CA (1)	CA2486336C (xx)
CY (1)	CY1105867T1 (xx)
DE (2)	DE10222192A1 (xx)
DK (1)	DK1509498T3 (xx)
ES (1)	ES2274264T3 (xx)
HR (1)	HRP20041078B1 (xx)
IL (2)	IL165213A0 (xx)
MA (1)	MA27277A1 (xx)
ME (1)	MEP28908A (xx)
MX (1)	MXPA04011497A (xx)
MY (1)	MY139310A (xx)
NO (1)	NO333288B1 (xx)
PE (1)	PE20040452A1 (xx)
PL (1)	PL209700B1 (xx)
PT (1)	PT1509498E (xx)
RS (1)	RS50772B (xx)
RU (1)	RU2315752C2 (xx)
TW (1)	TWI281467B (xx)
WO (1)	WO2003097591A1 (xx)
ZA (1)	ZA200408886B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7501440B2 (en)	2003-03-07	2009-03-10	Sanofi-Aventis Deutschland Gmbh	Substituted benzoylureidopyridylpiperidine-and-pyrrolidinecarboxylic acid derivatives, processes for preparing them and their use
DE10338554A1 (de) *	2003-08-22	2005-03-31	Aventis Pharma Deutschland Gmbh	Pentafluorosulfanylphenyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
OA13285A (en) *	2003-11-13	2007-01-31	Sanofi Aventis Deutschland	Pentafluorosulfanyl benzoylguanidines, method for their production, their use as medicaments or diagnostic agents and medicament containing the same.
DE10353204A1 (de) *	2003-11-13	2005-06-16	Aventis Pharma Deutschland Gmbh	Verfahren zur Herstellung von 4-Pentafluorsulfanyl-benzoylguanidinen
DE10353205A1 (de) *	2003-11-13	2005-06-16	Aventis Pharma Deutschland Gmbh	Ortho-substituierte Pentafluorsulfuranyl-Benzole, Verfahren zu ihrer Herstellung sowie ihre Verwendung als wertvolle Synthese-Zwischenstufen
DE102004043937A1 (de) *	2004-09-11	2006-03-30	Sanofi-Aventis Deutschland Gmbh	Ortho-substituierte Pentafluorsulfuranyl-Benzole, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Synthese-Zwischenstufen
DE102004043938A1 (de) *	2004-09-11	2006-03-30	Sanofi-Aventis Deutschland Gmbh	Pentafluorosulfanylphenyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CA2676147C (en) *	2007-02-09	2012-03-13	Pfizer Limited	Antiparasitic agents
EP2468719B1 (en) *	2007-03-23	2013-10-16	UBE Industries, Ltd.	Process for producing arylsulfur pentafluorides
WO2009028514A1 (ja) *	2007-08-28	2009-03-05	Ube Industries, Ltd.	ペンタフルオロスルファニルベンゼン化合物の製造方法、及び新規なペンタフルオロスルファニルベンゼン化合物
RU2372331C1 (ru) *	2008-05-14	2009-11-10	Сергей Михайлович Игумнов	СПОСОБ ПОЛУЧЕНИЯ ДИ(C1-C6 алкил)АМИНОТРИФТОРСУЛЬФУРАНОВ
JP5439745B2 (ja) *	2008-05-27	2014-03-12	宇部興産株式会社	ハロゲノメチルペンタフルオロスルファニルベンゼン化合物及びその製造方法
CN103974935B (zh) *	2011-12-06	2017-02-22	宇部兴产株式会社	五氟硫基苯甲酸的制造方法
CN108003034B (zh) *	2017-12-26	2020-07-03	金凯(辽宁)化工有限公司	一种2-甲基-5-氨基三氟甲苯的制备方法
RU2765117C2 (ru) *	2019-09-24	2022-01-25	Федеральное государственное автономное образовательное учреждение высшего образования "Уральский федеральный университет имени первого Президента России Б.Н. Ельцина"	Применение натриевой соли диэтилового эфира 4-оксо-1,4-дигидропиразоло[5,1-с]-1,2,4-триазин-3,8-дикарбоновой кислоты, моногидрата в качестве средства лечения и профилактики поздних осложнений сахарного диабета

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4417004A1 (de) *	1994-05-13	1995-11-16	Hoechst Ag	Perfluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19517848A1 (de) *	1995-05-16	1996-11-21	Merck Patent Gmbh	Fluorhaltige Benzoylguanidine
DE19526381A1 (de) *	1995-07-19	1997-01-23	Hoechst Ag	4-Fluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
GB9606015D0 (en) *	1996-03-22	1996-05-22	Rhone Poulenc Agriculture	New herbicides

2002
- 2002-05-18 DE DE10222192A patent/DE10222192A1/de not_active Withdrawn
2003
- 2003-04-25 PE PE2003000415A patent/PE20040452A1/es not_active Application Discontinuation
- 2003-05-05 EP EP03752723A patent/EP1509498B1/de not_active Expired - Lifetime
- 2003-05-05 DK DK03752723T patent/DK1509498T3/da active
- 2003-05-05 CA CA2486336A patent/CA2486336C/en not_active Expired - Fee Related
- 2003-05-05 HR HRP20041078AA patent/HRP20041078B1/hr not_active IP Right Cessation
- 2003-05-05 IL IL16521303A patent/IL165213A0/xx unknown
- 2003-05-05 ME MEP-289/08A patent/MEP28908A/xx unknown
- 2003-05-05 DE DE50305498T patent/DE50305498D1/de not_active Expired - Lifetime
- 2003-05-05 PL PL371784A patent/PL209700B1/pl unknown
- 2003-05-05 MX MXPA04011497A patent/MXPA04011497A/es active IP Right Grant
- 2003-05-05 CN CNB038113198A patent/CN100506791C/zh not_active Expired - Fee Related
- 2003-05-05 ES ES03752723T patent/ES2274264T3/es not_active Expired - Lifetime
- 2003-05-05 AU AU2003242531A patent/AU2003242531B2/en not_active Ceased
- 2003-05-05 RU RU2004137115/04A patent/RU2315752C2/ru not_active IP Right Cessation
- 2003-05-05 JP JP2004505324A patent/JP4383341B2/ja not_active Expired - Fee Related
- 2003-05-05 RS YUP-990/04A patent/RS50772B/sr unknown
- 2003-05-05 AT AT03752723T patent/ATE343563T1/de active
- 2003-05-05 KR KR1020047018590A patent/KR100977676B1/ko not_active Expired - Fee Related
- 2003-05-05 PT PT03752723T patent/PT1509498E/pt unknown
- 2003-05-05 WO PCT/EP2003/004669 patent/WO2003097591A1/de not_active Ceased
- 2003-05-05 BR BR0311128-8A patent/BR0311128A/pt not_active IP Right Cessation
- 2003-05-15 TW TW092113151A patent/TWI281467B/zh not_active IP Right Cessation
- 2003-05-16 AR ARP030101716A patent/AR040034A1/es active IP Right Grant
- 2003-05-16 MY MYPI20031822A patent/MY139310A/en unknown
2004
- 2004-11-03 ZA ZA2004/08886A patent/ZA200408886B/en unknown
- 2004-11-15 IL IL165213A patent/IL165213A/en not_active IP Right Cessation
- 2004-11-16 MA MA27949A patent/MA27277A1/fr unknown
- 2004-12-14 NO NO20045447A patent/NO333288B1/no not_active IP Right Cessation
2006
- 2006-12-20 CY CY20061101825T patent/CY1105867T1/el unknown

Also Published As

Publication number	Publication date
ES2274264T3 (es)	2007-05-16
PL209700B1 (pl)	2011-10-31
MY139310A (en)	2009-09-30
WO2003097591A1 (de)	2003-11-27
AR040034A1 (es)	2005-03-09
IL165213A (en)	2009-05-04
RU2004137115A (ru)	2005-05-27
CA2486336C (en)	2011-06-21
BR0311128A (pt)	2005-03-08
NO20045447L (no)	2004-12-14
EP1509498A1 (de)	2005-03-02
DE50305498D1 (de)	2006-12-07
EP1509498B1 (de)	2006-10-25
KR20040111635A (ko)	2004-12-31
HRP20041078B1 (hr)	2013-02-28
CY1105867T1 (el)	2011-02-02
CN1653044A (zh)	2005-08-10
IL165213A0 (en)	2005-12-18
RS50772B (sr)	2010-08-31
KR100977676B1 (ko)	2010-08-25
HK1076095A1 (zh)	2006-01-06
ATE343563T1 (de)	2006-11-15
ZA200408886B (en)	2006-01-25
RS99004A (sr)	2007-04-10
PL371784A1 (en)	2005-06-27
AU2003242531A1 (en)	2003-12-02
CA2486336A1 (en)	2003-11-27
DE10222192A1 (de)	2003-11-27
MA27277A1 (fr)	2005-04-01
DK1509498T3 (da)	2007-02-26
TW200407290A (en)	2004-05-16
HRP20041078A2 (en)	2005-04-30
RU2315752C2 (ru)	2008-01-27
CN100506791C (zh)	2009-07-01
TWI281467B (en)	2007-05-21
JP2005526138A (ja)	2005-09-02
AU2003242531B2 (en)	2008-07-31
NO333288B1 (no)	2013-04-29
PT1509498E (pt)	2007-01-31
PE20040452A1 (es)	2004-08-18
MXPA04011497A (es)	2005-02-14
JP4383341B2 (ja)	2009-12-16

Publication	Publication Date	Title
MEP28908A (en)	2010-10-10	Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
BR0312134A (pt)	2005-04-05	Benzoilguanidinas derivadas de cicloalquilas fluoradas e seu emprego como medicamento
BR0311556A (pt)	2005-04-12	Derivados de n-((3-oxo-2,3-diidro-1h-isoindol-1-il)acetil)guanidina como inibidores de nhe-1 para o tratamento de enfarte e angina pectoris
EA200500312A1 (ru)	2005-08-25	Новые спироконденсированные хиназолиноны и их применение в качестве ингибиторов фосфодиэстераз
NZ592741A (en)	2013-03-28	Thiochromene derivatives as hif hydroxylase inhibitors
ATE273305T1 (de)	2004-08-15	Thrombin-inhibitoren
BR0011745A (pt)	2002-03-19	Inibidores de aspartil protease
AR073117A1 (es)	2010-10-13	Derivado de aminometil-fenil-piperidin-1-il-indolil-metanona, inhibidores de la triptasa de mastocitos, composiciones farmaceuticas que lo contienen, metodo de preparacion, compuestos intermediarios y uso del compuesto en el tratamiento de procesos inflamatorios.
NO20065719L (no)	2006-12-12	I det vesentlige rene 2-{[2-(2-metylamino-pyrimidin-4-yl)-1H-indol-5-karbonyl]-amlno}-3-(fenylpyridin-2-yl-amino)-propionsyre som en IkB kinaseinhibitor.
EP1500648A4 (en)	2005-12-21	NEW PIPERIDINE DERIVATIVES
PT81286B (pt)	1988-02-17	Processo para a preparacao de derivados de tetrahidronaftaleno e de composicoes farmaceuticas que os contem
Gavara et al.	2022	1, 2, 4-Triazole-3-thione analogues with an arylakyl group at position 4 as metallo-β-lactamase inhibitors
ATE296802T1 (de)	2005-06-15	Substituierte heterocyclo-norbornylamino-derivate,verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament
BR0312701A (pt)	2005-04-26	Derivados de 3-guanidinocarbonil-1-hete-roaril-indol, processo de preparação, seu uso como medicamentos e composições farmacêuticas os compreendendo
BRPI0518000A (pt)	2008-10-21	tetrahidroisoquinolinas aril- e heteroaril- substituìdas e uso das mesmas para bloquear a reabsorção de norepinefrina, dopamina e serotonina
WO2004007478A3 (en)	2004-02-19	Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use
ES2142895T3 (es)	2000-05-01	Guanidinas sustituidas con diacilo, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
BR0312183A (pt)	2005-04-05	Uso de compostos benzisosselenazolonas contra lesão miocárdica isquêmica
DK1896416T3 (da)	2009-02-23	Substituerede heterocykliske forbindelser, deres anvendelse som medikament og farmaceutiske præparater, der omfatter disse
ECSP066563A (es)	2006-10-17	Pentafluorosulfanil-benzoilguanidinas, método para su producción, su uso como medicamentos o agentes de diagnóstico, y medicamento que las contiene
ECSP10010040A (es)	2010-04-30	Nuevas sales de adición de inhibidores de la enzima de conversión de l angiotensina a ácidos donadores de monoxido de nitrigeno (no), su procedimiento de preparación y las composiciones farmacéuticas que las contienen
MX2024007587A (es)	2024-07-04	Sal derivada de triazolona como inhibidor de elastasa de neutrofilos.
BR0314714A (pt)	2005-08-02	Compostos para o tratamento da doença de alzheimer
BR0307495A (pt)	2004-12-28	Diidro-tia-fenantreno-carbonil-guanidinas, processo para sua preparação, seu uso como medicamento ou agente de diagnóstico
BR0312615A (pt)	2005-04-19	Compostos úteis como inibidores de metaloproteinases